Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer-Reference-Cited by-同舟云学术

Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer

Published:2014-07 Issue:11 Volume:50 Page:1864-1871
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Groheux David,Hindié Elif,Giacchetti Sylvie,Hamy Anne-Sophie,Berger Frederique,Merlet Pascal,de Roquancourt Anne,de Cremoux Patricia,Marty Michel,Hatt Mathieu,Espié Marc

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Triple-negative breast cancer;Foulkes;N Engl J Med,2010

2. Triple-negative breast cancers: epidemiological considerations and recommendations;Boyle;Ann Oncol,2012

3. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer;Liedtke;J Clin Oncol,2008

4. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von Minckwitz;J Clin Oncol,2012

5. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures;Fuster;J Clin Oncol,2008

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress;Diagnostics;2024-09-03

2. Role of [18F]FDG PET/CT in patients with no special type breast cancer: Literature review and comparison between guidelines;The Breast;2024-09

3. Changes in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival;Breast Cancer Research and Treatment;2024-05-23

4. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-14

5. Fluorine-18 FDG PET/CT and New NIMS Grading System for Chemotherapy Response in Breast Cancer;Indian Journal of Nuclear Medicine;2024-03